Connect Biopharma Holdings (Connect Biopharma Holdings) PB Ratio

: 0.74 (As of Today)

View and export this data going back to 2021. Start your Free Trial

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-04-23), Connect Biopharma Holdings's share price is $1.35. Connect Biopharma Holdings's Book Value per Share for the quarter that ended in Dec. 2023 was $1.83. Hence, Connect Biopharma Holdings's PB Ratio of today is 0.74.

The historical rank and industry rank for Connect Biopharma Holdings's PB Ratio or its related term are showing as below:

CNTB' s PB Ratio Range Over the Past 10 Years
Min: 0 Med: 0 Max: 6.73
Current: 0.74

During the past 5 years, Connect Biopharma Holdings's highest PB Ratio was 6.73. The lowest was 0.00. And the median was 0.00.

CNTB's PB Ratio is ranked better than
85.42% of 1310 companies
in the Biotechnology industry
Industry Median: 2.36 vs CNTB: 0.74

During the past 12 months, Connect Biopharma Holdings's average Book Value Per Share Growth Rate was -35.90% per year.

Back to Basics: PB Ratio

Connect Biopharma Holdings PB Ratio Historical Data

The historical data trend for Connect Biopharma Holdings's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Connect Biopharma Holdings Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

PB Ratio

1.04

0.30

0.64

Connect Biopharma Holdings Semi-Annual Data
	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
PB Ratio					1.04	0.22	0.30	0.49	0.64

Competitive Comparison

For the Biotechnology subindustry, Connect Biopharma Holdings's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Connect Biopharma Holdings PB Ratio Distribution

For the Biotechnology industry and Healthcare sector, Connect Biopharma Holdings's PB Ratio distribution charts can be found below:

* The bar in red indicates where Connect Biopharma Holdings's PB Ratio falls into.

Connect Biopharma Holdings PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Connect Biopharma Holdings's PB Ratio for today is calculated as follows:

PB Ratio	=	Share Price	/	Book Value per Share (Q: Dec. 2023)
	=	1.35	/	1.834
	=	0.74

It can also be calculated from the numbers for the whole company:

PB Ratio

Market Cap

(Total Stockholders Equity

Preferred Stock)

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.

Connect Biopharma Holdings (NAS:CNTB) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.

Connect Biopharma Holdings PB Ratio Related Terms

Thank you for viewing the detailed overview of Connect Biopharma Holdings's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Connect Biopharma Holdings (Connect Biopharma Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Connect Biopharma Holdings Ltd (NAS:CNTB) » Definitions » PB Ratio

Comparable Companies

Traded in Other Exchanges

N/A

Address

12265 El Camino Real, Suite 350, San Diego, CA, USA, 92130

Website

https://www.connectbiopharm.com

Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.